OpenBilldrug price receipt

NADAC week of 2026-10-14

FT ACID REDUCER DR 20 MG CAP

FDA nonproprietary name: esomeprazole

For 30 capsules

Pharmacies pay

$10.38 filed

30 × $0.34596 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$16.94 estimated

$10.38 + $1.56 (15%) + $5.00 fee per fill = $16.94

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FT ACID REDUCER DR 20 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as esomeprazole, under the trade name “Foster and Thrive Acid Reducer”.

FDA gives its dosage form as capsule, delayed release and its route as oral.

The labeler, the company named on the label, is Strategic Sourcing Services LLC.

FDA’s Established Pharmacologic Class for it is Proton Pump Inhibitor.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and marks it as sold over the counter.

What pharmacies pay

Pharmacies pay $10.38 for 30 capsules (30 × $0.34596 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 3 NDCs

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name esomeprazole with FT ACID REDUCER DR 20 MG CAP.

ProductPharmacies pay per unitMedicare per unit
ESOMEPRAZOLE MAG DR 20 MG CAP
generic · capsule, delayed release pellets / capsule, delayed release / capsule, coated pellets
$0.14458 to $0.34596 per EA filed
eff. 2026-09-23 to 2026-09-30
We don’t know yet
FT ACID REDUCER DR 20 MG CAP this page
generic · capsule, delayed release
$0.34596 per EA filed
eff. 2026-09-23
We don’t know yet
GNP ESOMEPRAZOLE MAG DR 20 MG
generic · capsule, delayed release
$0.34596 per EA filed
eff. 2026-09-23
We don’t know yet
GS ESOMEPRAZOLE MAG DR 20 MG
generic · capsule, delayed release
$0.34596 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $0.34596 per EA filed.

Of the 61 other products in FDA’s Proton Pump Inhibitor class priced per EA, 49 have a higher middle NADAC price and 10 a lower one; 2 have the same. The one in the middle is LANSOPRAZOLE DR 30 MG ODT, at $2.25583 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.